Cochrane Abstracts
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Nebulized and Oral Thiol Derivatives for Pulmonary Disease in Cystic Fibrosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432482/all/Nebulized_and_oral_thiol_derivatives_for_pulmonary_disease_in_cystic_fibrosis.
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432482/all/Nebulized_and_oral_thiol_derivatives_for_pulmonary_disease_in_cystic_fibrosis. Accessed December 8, 2024.
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432482/all/Nebulized_and_oral_thiol_derivatives_for_pulmonary_disease_in_cystic_fibrosis
Nebulized and Oral Thiol Derivatives for Pulmonary Disease in Cystic Fibrosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432482/all/Nebulized_and_oral_thiol_derivatives_for_pulmonary_disease_in_cystic_fibrosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis
ID - 432482
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432482/all/Nebulized_and_oral_thiol_derivatives_for_pulmonary_disease_in_cystic_fibrosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
